Pharma By Isabella Cueto Aug. 9, 2024 Neffy, the new nasal spray for severe allergic reactions, is approved for use in people 66 pounds and above.Courtesy ARS Pharma On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor from ARS...
Medscape Medical News Sari Harrar August 09, 2024 A surprising therapy is showing promise for chronic pain, vision loss, and muscle recovery, among other conditions. It’s not a pill, an injection, or surgery. It’s light. Yes, light. The thing that appears when you open the curtains, flip a switch, or strike a match. Light illuminates...
Medscape Medical News Richard Mark Kirkner August 08, 2024 Emerging diagnostic technology that uses artificial intelligence (AI) has demonstrated the potential to free dermatologists from the burden of triaging skin lesions, but dermatology lags behind some other specialties in harnessing the power of AI, and confusion surrounds dermatologists’ role in using this technology, according to...
Medscape Family Medicine > Clinical Guidelines for Primary CareCOMMENTARY Neil Skolnik, MD DISCLOSURES | August 07, 2024 This transcript has been edited for clarity. I’m Dr Neil Skolnik and today we are going to talk about the position statement from the American Headache Society (AHS) “Calcitonin Gene-Related Peptide-Targeting Therapies Are a First-Line Option for the...
Dive Brief Inspire plans to start a soft launch of the device late in 2024 and move into a full release in 2025. Published Aug. 5, 2024 By Nick Paul TaylorContributor Inspire Medical Systems’ patient app and remote. Courtesy of Inspire Medical Systems Dive Brief:Inspire Medical Systems received Food and Drug Administration approval for its...
by Nathaniel Weixel – 08/08/24 1:51 PM ET COVID-19 killed far fewer Americans in 2023 than 2022, according to provisional data from the Centers for Disease Control and Prevention (CDC). The percentage of people who died from the disease dropped nearly 69 percent last year, and COVID-19 was listed as the 10th leading cause of...
Delirium Improving Symptoms of Chronic Schizophrenia in Elderly: A Case SeriesClinical Medical Reviews and Case Reports Prerak Kumar1*, Shailendra Mohan Tripathi2, Richa Shukla1 and Roshni Basu1 1Senior Resident, Department of Geriatric Mental Health, King George’s Medical University, Lucknow, Uttar Pradesh, India 2Additional Professor, Department of Geriatric Mental Health, King George’s Medical University, Lucknow, Uttar Pradesh,...
